News
- University of Bristol and UCL to lead support hub for UK's longitudinal population studies 27 March 2024 The University of Bristol and UCL will lead the Population Research UK (PRUK) co-ordination hub, part of an existing strategic investment from the UKRI Infrastructure Fund.
- Patient recovery after surgery for oesophageal cancer isn’t influenced by using standard or keyhole incisions 26 March 2024 New research has found no evidence of a difference between recovery time and complications when comparing standard and keyhole surgical incisions for the treatment of oesophageal cancer (cancer of the gullet). The study, led by the University of Bristol Medical School and published in the British Journal of Surgery, showed surgeons treating patients with oesophageal cancer do not need to change their practice if they have a strong preference for either procedure type.
- New cancer and domestic abuse toolkit launched 26 March 2024 A new toolkit to support cancer professionals to identify and respond to signs of domestic abuse in patients with cancer and their carers is being launched today [26 March]. The toolkit has been developed in partnership with the University of Bristol, Standing Together Against Domestic Abuse, and Macmillan Cancer Support.
- Bristol leaps ahead in training next generation of leaders to tackle major global challenges 12 March 2024 Hundreds of talented scientists and engineers are set to advance solutions for some of the world’s most pressing challenges, ranging from reaching net-zero and developing sustainable energy to improving digital security and making the latest health breakthroughs.
- New Digital Health Hub launches in South West England and Wales 11 March 2024 A consortium of universities from across the South West of England and Wales have come together to form a brand new Digital Health Hub which will elevate the region’s digital health capability through leadership, engagement, acceleration and partnership (LEAP).
- Anti-diabetic drugs could lower risk of primary and secondary brain cancer 22 February 2024 Diabetic patients who take anti-diabetic drugs - known as glitazones – long term had a lower risk of primary and secondary brain cancer compared with diabetic patients on other medications, new research led by the University of Bristol has found.
- Fakes, facts, society and health 8 February 2024 The Elizabeth Blackwell Institute for Health Research welcomed Patricia Kingori, Professor of Global Health Ethics at the University of Oxford, as their 10th Annual Public Lecture speaker.
- Nurturing Equality, Diversity and Inclusion - Supporting Research Careers in Health and Biomedicine 8 February 2024
- Bristol scientists supercharge Artificial Intelligence in revolutionary £80 million national initiative 6 February 2024 Experts are helping put the UK at the forefront of AI advances, using it to transform current uses and tackle important global challenges.
- Weight loss intervention in people with type 2 diabetes influences cancer-associated proteins 30 January 2024 A weight loss intervention in people with type 2 diabetes was found to alter levels of cancer-related proteins, according to the findings of a new University of Bristol-led study. The study is the first to show that weight loss in people recently diagnosed with diabetes can change the levels of cancer-related chemicals circulating in the blood.
Cancer research press releases
Press releases relating to cancer research on the University's central news pages.
Bristol Cancer newsletters
View previous Bristol Cancer newsletters with staff and research news 2015-2023.
Join the Network
Complete our form to join the Bristol Cancer Research Network.